Navigation Links
New: Longevinex(R) First to Introduce Micronized Resveratrol Matrix - Now Stabilized by Microencapsulation
Date:4/22/2008

SAN DIMAS, Calif., April 22 /PRNewswire/ -- To enhance absorption, the Longevinex(R) matrix of nutraceuticals now features micron-sized trans-resveratrol, microencapsulated in an envelope of all natural plant dextrins and starches to preserve resveratrol in its trans-resveratrol form from degradation by light, heat and oxygen. (Refs 1, 2)

(Photo: http://www.newscom.com/cgi-bin/prnh/20080422/LATU004 )

The newly formulated Longevinex resveratrol matrix withstands direct exposure to solar ultraviolet radiation and heat in independent laboratory tests, says Bill Sardi, spokesperson for Longevinex. (To learn more about microencapsulation online, visit: http://en.wikipedia.org/wiki/Micro-encapsulation )

Microencapsulation protects resveratrol from environmental factors before it is encapsulated into a larger oral capsule. Microencapsulation also facilitates slow release and better absorption.

The ingredients in Longevinex(R) capsules are newly formulated to provide rice bran ferulate, and natural vitamin D3.

The ingredients in Longevinex(R) work additively and synergistically, says Sardi. Vitamin D3 works to breakdown rice bran IP6, a whole-grain factor also provided in Longevinex, into IP3, which is its primary active form. Quercetin allows more resveratrol to pass through the liver before it is metabolized, improving immediate bioavailability of resveratrol.

A drawback of most resveratrol supplements is their emodin content. Small amounts of emodin can induce loose stool in sensitive individuals. Resveratrol in Longevinex(R) is a purified form that is virtually emodin-free.

The newly formulated Longevinex(R) matrix is produced in a vege-capsule, to meet requirements of vegetarians.

Longevinex(R) provides a unique array of mineral chelators (patent applied for) based around an over-mineralization theory of aging, explained at its website.

Longevinex(R) is the first and only resveratrol-based dietary supplement to be shown to be efficacious in a human study (reduced markers of oxidation and inflammation among endurance athletes in independent study conducted by researchers at Appalachian State University). For more information visit: http://www.longevinex.com or call 1 866-405-4000.

(1) Reference/ Resveratrol is not stable at room temperature without

protection from light. Research center: Department of Medicinal

Chemistry and Pharmacognosy, College of Pharmacy, University of

Illinois at Chicago, Chicago, Illinois. Title: An LC-MS method for

analyzing total resveratrol in grape juice, cranberry juice, and in

wine. Journal: Journal Agriculture Food Chemistry Volume 50, Number

3, pages 431-35, January 2002.

(2) Resveratrol is unstable against light, heat, wet-heating and oxygen.

Research center: College of Life Sciences and Engineering, Shaanxi

University of Science & Technology, Xianyang China. Title: Study on

the stability of resveratrol in rhizoma polygoni cuspidate. Journal:

Zhong Yao Cai. Volume 30, Number 7, pages 805-07, 2007.


'/>"/>
SOURCE Longevinex
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
2. Darwin to Announce First Quarter 2008 Financial Results
3. Omnicell Announces First Quarter 2008 Results
4. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
5. Old Orchard Introduces First Multi-Serve Vitamin Water, Sweetened with Agave Nectar and Real Fruit Juice
6. Survey offers first-ever look at treatment practices for nonepileptic seizures
7. HMS Holdings Corp. Hosts First Quarter 2008 Financial Teleconference and Presentation
8. Sorrento(R) Cheese Launches First Omega-3 Cheese on the Market
9. Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
10. QLT announces first quarter 2008 Visudyne(R) sales
11. Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: